Ferrante Karen Jean 4
4 · Cogent Biosciences, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Ferrante Karen Jean
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-07-01+3,314→ 3,314 totalExercise: $7.22From: 2025-07-01Exp: 2035-07-01→ Common Stock (3,314 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.